Systemic Delivery of MicroRNA-101 Potently Inhibits Hepatocellular Carcinoma In Vivo by Repressing Multiple Targets

Targeted therapy based on adjustment of microRNA (miRNA)s activity takes great promise due to the ability of these small RNAs to modulate cellular behavior. However, the efficacy of miR-101 replacement therapy to hepatocellular carcinoma (HCC) remains unclear. In the current study, we first observed...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Fang, Liao, Yi-Ji, Cai, Mu-Yan, Liu, Tian-Hao, Chen, Shu-Peng, Wu, Pei-Hong, Wu, Long, Bian, Xiu-Wu, Guan, Xin-Yuan, Zeng, Yi-Xin, Yuan, Yun-Fei, Kung, Hsiang-Fu, Xie, Dan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4334495/
https://www.ncbi.nlm.nih.gov/pubmed/25693145
http://dx.doi.org/10.1371/journal.pgen.1004873

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4334495/
https://www.ncbi.nlm.nih.gov/pubmed/25693145
http://dx.doi.org/10.1371/journal.pgen.1004873

Ejemplares similares